Sign in
4

Changes in Ownership

Candel Therapeutics, Inc. Filed Acc 0000899243-22-008373

Options or other derivatives

  • Chief Executive Officer acquired 330,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Tak Paul Peter Chief Executive Officer 2022-02-28 Grant or award · Stock Option (Right to Buy) +330,000 330,000 D
Loading xslF345X03/doc4.xml…